| Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire SE Alters, JR Gadea, M Sorich, G O'Donoghue, S Talib, R Philip Journal of Immunotherapy 21 (1), 17-26, 1998 | 72 | 1998 |
| IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy SE Alters, JR Gadea, B Holm, J Lebkowski, R Philip Journal of Immunotherapy 22 (3), 229-236, 1999 | 57 | 1999 |
| Immunotherapy of cancer: generation of CEA specific CTL using CEA peptide pulsed dendritic cells SE Alters, JR Gadea, R Philip Dendritic Cells in Fundamental and Clinical Immunology: Volume 3, 519-524, 1997 | 56 | 1997 |
| Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses … R Philip, SE Alters, E Brunette, J Ashton, J Gadea, J Yau, J Lebkowski, ... Journal of Immunotherapy 23 (1), 168-176, 2000 | 42 | 2000 |
| Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors R Philip, E Brunette, J Ashton, S Alters, J Gadea, M Sorich, J Yau, ... Cancer Gene Therapy 5 (4), 236-246, 1998 | 38 | 1998 |
| Gene modified and peptide pulsed dendritic cells for the generation of active immunotherapy strategies R Philip, E Brunette, S Alters, J Gadea, H Zheng, J Yau, M Philip Immunology Letters 1 (56), 159, 1997 | 4 | 1997 |
| Generation of antigen specific CTL using peptide and gene modified dendritic cells J Gadea, E Brunette, M Philip, HK Lyeriy, R Philip, S Alters Proc. Am. Assoc. Cancer Res.[abstr] 3154, 1996 | 4 | 1996 |
| IL—13 Can Substitute for IL—4 in the Generation of Dendritic Cells for the Induction of Cytotoxic T Lymphocytes and SE Alters, JR Gadea, B Holm, J Lebkowski, R Philip Journal of1mmmini/wrap 22 (3), 229-236, 1999 | | 1999 |
| Engineered dendritic and T cell populations for active and adoptive immunotherapy of malignancies J Lebkowski, S Talib, M Philip, S Alters, A Muniappan, J Gadea, ... CANCER GENE THERAPY 4 (6), O127-O127, 1997 | | 1997 |
| Engineered dendritic and T cell populations for active and adoptive immunotherapy of malignancies. J Lebkowski, R Philip, S Talib, S Alters, A Muniappan, J Gadea, ... BLOOD 88 (10), 988-988, 1996 | | 1996 |
| Ex vivo stimulation and culture of antigen specific T-cell populations using peptide or gene modified dendritic cells for the treatment of malignancies. J Lebkowski, S Alters, J Gadea, E Brunette, G ODonoghue, S Talib, ... CANCER GENE THERAPY 3 (6), O58-O58, 1996 | | 1996 |
| Ex vivo stimulation and culture of antigen specific T cell populations for the treatment of malignancies. JS Lebkowski, S Alters, J Gadea, B Vertin, L Kilinski, TB Okarma, R Philip EXPERIMENTAL HEMATOLOGY 24 (9), 365-365, 1996 | | 1996 |
| Ex vivo generation of antigen specific T cell populations for the treatment of infectious diseases and cancer. JS Lebkowski, S Alters, K Weinhold, E Paoletti, W Cox, J Tartaglia, ... BLOOD 86 (10), 1694-1694, 1995 | | 1995 |
| Characterization and Gene Modification of Dendritic Cells to be Used for Antigen Presentation S Alters, J GADEA, E BRUNETTE, L KILINSKI, M PHILIP, R PHILIP JOURNAL OF CELLULAR BIOCHEMISTRY, 24-24, 1995 | | 1995 |
